ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Clinical trial NCT03671889 · RECRUITING

Trial details

NCT number: NCT03671889
Sponsor: InSightec
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-09-28
Primary completion: 2028-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.